skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Go inside the news and trends impacting patient market access with In Vivo

Your free mini-mag includes pieces that take you deep into the issues affecting market access. Know what’s happening now and what’s on the horizon with articles including: 
“Market Access 2020: Understanding US Payer Expectations”
“From US To EU: Young Biotechs Going It Alone”
“The SMA Market: Assessing The Unknowns”

Capture essential CAR-T patient market access data with In Vivo’s free infographic, “Accessing CAR-T Therapies”. It’s a data-rich, snapshot view of the complex factors contributing to worldwide market access and includes:
Overview of Novartis’ Kymriah
Overview of Gilead Sciences’ Yescarta
Overview of the autologous CAR-T pipeline
Overview of the allogenic CAR-T pipeline
CAR-T development areas
Approvals vs. access for CAR-T therapies worldwide
Pipeline by disease area

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: